Clinical Trials Browser

Has results × Mesothelioma × tazemetostat × Clear all

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Mesothelioma, Sarcoma, Sarcoma, Synovial, Lymphoma, Large B-Cell, Diffuse, Rhabdoid Tumor, Hematologic Neoplasms

NCT02860286 2021-04-09

Study of the EZH2 Inhibitor Tazemetostat in Malignant Mesothelioma

Phase 2 Completed

74 enrolled 23 charts

Other solid neoplasmThoracic

Mesothelioma

Clinical Trials

Effects of Itraconazole and Rifampin on the Blood Tazemetostat Levels

Study of the EZH2 Inhibitor Tazemetostat in Malignant Mesothelioma